Arefeh Seyedarabi
- Endocrinology top 10%
- Biotechnology top 10%
-
- Protein Interaction Studies and Fluorescence Analysis 6
-
- Alzheimer's disease research and treatments 7
- Spaceflight effects on biology 4
-
- Hydrogen's biological and therapeutic effects 6
-
- Medical and Biological Ozone Research 6
-
- Proteins in Food Systems 3
-
- Nanoparticles: synthesis and applications 3
-
- Computational Drug Discovery Methods 3
- Co-authors
- Adeleh DivsalarAli Akbar SabouryRichard W. PickersgillJavad BahararaTayebe RamezaniChihiro SasakawaAli Akbar Moosavi‐MovahediMartin J. Warren
- Partner nations
- IranUnited KingdomHungary
In The Last Decade
Arefeh Seyedarabi
39 papers receiving 775 citations
Peers
Comparison fields: 5 of 103
- Endocrinology 58
- Biotechnology 62
- Biomaterials 84
- Molecular Biology 345
- Clinical Biochemistry 32
Countries citing papers authored by Arefeh Seyedarabi
This map shows the geographic impact of Arefeh Seyedarabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arefeh Seyedarabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arefeh Seyedarabi more than expected).
Fields of papers citing papers by Arefeh Seyedarabi
This network shows the impact of papers produced by Arefeh Seyedarabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arefeh Seyedarabi. The network helps show where Arefeh Seyedarabi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arefeh Seyedarabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 29 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 21 | |
| 13 | 2018 | 14 | |
| 14 | 2013 | 12 | |
| 15 | 2013 | 11 | |
| 16 | 2012 | 56 | |
| 17 | 2012 | 34 | |
| 18 | 2010 | 1 | |
| 19 | 2006 | 19 | |
| 20 | 2005 | 98 |
About Arefeh Seyedarabi
Arefeh Seyedarabi is a scholar working on Pharmacology, Filtration and Separation and Physiology, having authored 44 papers that have together received 787 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Hydrogen's biological and therapeutic effects (6 papers), Protein Interaction Studies and Fluorescence Analysis (6 papers), Medical and Biological Ozone Research (6 papers), Spaceflight effects on biology (4 papers), Proteins in Food Systems (3 papers), Nanoparticles: synthesis and applications (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Endocrinology (58 citations), Biotechnology (62 citations) and Biomaterials (84 citations). Arefeh Seyedarabi has collaborated with scholars based in Iran, United Kingdom and Hungary. Frequent co-authors include Adeleh Divsalar, Ali Akbar Saboury, Richard W. Pickersgill, Javad Baharara, Tayebe Ramezani, Chihiro Sasakawa, Ali Akbar Moosavi‐Movahedi, Martin J. Warren, Mehran Habibi-Rezaei and Takahito Toyotome. Their work appears in journals such as PLoS ONE, Biochemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.